On Mar 2, 2022 Rondo Therapeutics closed a Series A round and raised $67,000,000 from Canaan Partners, Johnson & Johnson Innovation – JJDC, Novo Holdings, […]
Post-IPO Debt – Bio-Rad Laboratories
On Mar 2, 2022 Bio-Rad Laboratories closed a Post-IPO Debt round and raised $1,200,000,000 from investors, featuring lead investors . About the company: Bio-Rad Laboratories […]
Series A – Alimetry
On Mar 2, 2022 Alimetry closed a Series A round and raised $16,300,000 from IP Group, K1W1, Matū Fund, Movac, Uniservices, featuring lead investors Movac. […]
Series A – Stämm Biotech
On Feb 28, 2022 Stämm Biotech closed a Series A round and raised $17,000,000 from Decarbonization Consortium, Dragones VC, Draper Associates, Draper Cygnus, GRID EXPONENTIAL, […]
Post-IPO Equity – BioVaxys
On Feb 28, 2022 BioVaxys closed a Post-IPO Equity round and raised $798,500 from investors, featuring lead investors . About the company: BioVaxys is located […]
Series C – SeLux Diagnostics
On Feb 28, 2022 SeLux Diagnostics closed a Series C round and raised $50,000,000 from Northpond Ventures, RA Capital Management, Sands Capital, Schooner Capital, featuring […]
Funding Round – Cell-Easy
On Feb 28, 2022 Cell-Easy closed a Funding Round round and raised €7,800,000 from Bpifrance, Région Occitanie, featuring lead investors Bpifrance. About the company: Cell-Easy […]
Series C – Biomason
On Feb 28, 2022 Biomason closed a Series C round and raised $65,000,000 from 2150, Celesta Capital, Hartree Partners, Martin Marietta, Novo Holdings, featuring lead […]
Series C – SeLux Diagnostics
On Feb 28, 2022 SeLux Diagnostics closed a Series C round and raised $50,000,000 from Northpond Ventures, RA Capital Management, Sands Capital, Schooner Capital, featuring […]
Funding Round – Cell-Easy
On Feb 28, 2022 Cell-Easy closed a Funding Round round and raised €7,800,000 from Bpifrance, Région Occitanie, featuring lead investors Bpifrance. About the company: Cell-Easy […]
